{"title":"Evaluation of Cases of Long-Coronavirus Disease-2019 Reported as being Readmitted to Intensive Care Units Due to Acute Respiratory Failure: Correspondence","authors":"Hinpetch Daungsupawong, Viroj Wiwanitkit","doi":"10.5152/ThoracResPract.2024.24075","DOIUrl":"10.5152/ThoracResPract.2024.24075","url":null,"abstract":"","PeriodicalId":75221,"journal":{"name":"Thoracic research and practice","volume":"1 1","pages":"85-86"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796291/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evaluation of Risk Factors Causing Diagnostic Delay in Non-steroidal Anti-inflammatory Drug-exacerbated Respiratory Disease.","authors":"Melek Cihanbeylerden, Hazal Kayıkçı, Çise Tüccar, Ebru Damadoğlu, Gül Karakaya, Ali Fuat Kalyoncu","doi":"10.4274/ThoracResPract.2024.24087","DOIUrl":"10.4274/ThoracResPract.2024.24087","url":null,"abstract":"<p><strong>Objective: </strong>Non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (N-ERD) can be difficult to diagnose due to the heterogeneity of phenotypes and a lack of validated in vitro tests. This study aimed to provide a better understanding of the course of N-ERD disease, analyze whether there was a delay in clinical diagnosis, and explore the factors that might cause diagnostic delay.</p><p><strong>Material and methods: </strong>This observational, cross-sectional, study included patients aged over 18. The time taken by clinicians to diagnose N-ERD was recorded as the clinician diagnosis time, while the time taken by patients to complete the N-ERD triad was recorded as the actual diagnosis time. A difference of six months or longer between actual diagnosis and clinician diagnosis times was accepted as diagnostic delay. Statistical analyses were performed to ascertain the parameters that could cause this delay.</p><p><strong>Results: </strong>The study included a total of 107 patients diagnosed with N-ERD. The patients had been diagnosed with chronic rhinosinusitis with nasal polyps, asthma, and NSAID hypersensitivity for an average duration of 14.9±9.6, 14.3±9.9, and 11.7±9.3 years, respectively. Thirty-nine (36.4%) of the patients had a delayed diagnosis. The mean delay in the diagnosis of N-ERD was 7.4±6.6 (2.0-12.0) years. Delayed diagnosis showed a correlation with thyroid dysfunction (<i>P</i> = 0.021), while it did not have a significant relationship with the remaining factors.</p><p><strong>Conclusion: </strong>The results of this study have indicated delays in diagnosing N-ERD patients and emphasized the need for adequately recognizing the disease to initiate timely, appropriate treatment.</p>","PeriodicalId":75221,"journal":{"name":"Thoracic research and practice","volume":"26 2","pages":"77-84"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796297/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Medical Students' Tobacco Consumption Status and Experiences with Smoke-free Law Violations in Enclosed Spaces in Türkiye and Northern Cyprus.","authors":"Dilek Aslan, Pınar Ay, Kervin Raymond, Özen Aşut, Gulifeiya Abuduxike, Meltem Şengelen, Duygu Çekici, Füsun Yıldız, Emine Ünal Evren, Ali Fuat Kalyoncu, Elif Dağlı","doi":"10.4274/ThoracResPract.2024.24084","DOIUrl":"10.4274/ThoracResPract.2024.24084","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to determine the frequency of tobacco smoking among medical students and assess their exposure to violations of smoke-free laws in enclosed spaces 30 days before the study. It also identifies key locations where such infractions occur and explores associated factors.</p><p><strong>Material and methods: </strong>A descriptive study was conducted using a questionnaire-based survey among students from two public and two private medical faculties in Türkiye and Northern Cyprus in 2023. Of the invited students, 628 responded. Data were analyzed using IBM Statistical Package for the Social Sciences statistics for Windows, version 23.0. Descriptive statistics included frequencies, percentages, means±standard deviations, and medians (interquartile ranges). Relationships between categorical variables were assessed using chi-squared and Fisher's exact tests, with significance set at <i>P</i> < 0.05. Binary logistic regression analysis of predictors of exposure to smoke-free violations was conducted. Ethical approval was obtained from each university.</p><p><strong>Results: </strong>Most participants were female (56.4%), with a mean age of 21.5±2.37 years. Nearly one in five students was a current tobacco user (19.9%). Smokers had higher exposure to passive smoking than non-smokers (92.0% vs. 82.5%, <i>P</i> = 0.009). Encountering tobacco industry-branded vehicles was associated with higher exposure (92.3% vs. 83.7%, <i>P</i> = 0.03). Exposure to violations of the antismoking ban in enclosed spaces was significantly higher among students who smoked with higher frequency (odds ratio: 2.418, 95% confidence interval: 1.172 to 4.990, <i>P</i> = 0.017).</p><p><strong>Conclusion: </strong>This study underscores the need for strict tobacco control among medical students, with an emphasis on advocacy and interdisciplinary collaboration to combat the tobacco industry's influence.</p>","PeriodicalId":75221,"journal":{"name":"Thoracic research and practice","volume":"26 2","pages":"48-54"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796294/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Moving Toward a Smoke-free Campus: A Survey of Students' Knowledge, Behavior, and Opinions.","authors":"Ülken Tunga Babaoğlu, Hüseyin İlter","doi":"10.4274/ThoracResPract.2024.24099","DOIUrl":"10.4274/ThoracResPract.2024.24099","url":null,"abstract":"<p><strong>Objective: </strong>This study examines the tobacco and product use status of university students, their awareness of smoke-free campuses, and the relationship between tobacco use awareness and tobacco use status.</p><p><strong>Material and methods: </strong>Data were collected using a questionnaire for students (n = 15.515) who continued their education at a state university. The questionnaire consisted of three sections: sociodemographic, tobacco and product use behaviors, and a Smoke-free Campus Awareness Scale (SCAS). The chi-square test was used for categorical variables, and the Kruskal-Wallis test was used for continuous variables.</p><p><strong>Results: </strong>28.5% of the university students were active smokers, and 48.7% were exposed to passive smoking on campus. When the SCAS scores were compared according to the smoking status of the students, never smokers (median: 44.0, Q1=36.0-Q3=48.0), active smokers (median: 27.0, Q1=20.0-Q3=36.0), and recent quitters (median: 33.0-Q1=11.0-Q3=43.0) (<i>P</i> < 0.001). SCAS scores were compared according to gender; the median score of female students (Q1=31.0-Q3=46.0) was statistically higher than that of male students (Q1=19.0-Q3=44.0). Non-smokers were found to be statistically more uncomfortable with being exposed to secondhand smoke on campus than smokers (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Most students were unaware of the smoke-free campus policy but were aware that passive smoking is an important public health problem. The fact that male students and smokers oppose implementation requires investigation of the reasons for these attitudes in future studies, and monitoring tobacco use trends after implementation is important to effectively evaluate smoke-free campus implementation.</p>","PeriodicalId":75221,"journal":{"name":"Thoracic research and practice","volume":"26 2","pages":"69-76"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796306/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Remziye Can, Elif Saraç, Esra Yıldız, Şerif Kurtuluş
{"title":"Third-hand Smoking Beliefs in Patients with Cancer.","authors":"Remziye Can, Elif Saraç, Esra Yıldız, Şerif Kurtuluş","doi":"10.4274/ThoracResPract.2024.24054","DOIUrl":"10.4274/ThoracResPract.2024.24054","url":null,"abstract":"<p><strong>Objective: </strong>Exposure to third-hand smoke (THS) represents an important health concern in many indoor environments. This study was conducted to test the beliefs of cancer patients about THS and to examine associations with effective factors.</p><p><strong>Material and methods: </strong>This cross-sectional study included 119 patients who were being treated for cancer in the oncology clinic of a University Hospital. The data were collected using a face-to-face questionnaire. This study consisted of the introductory characteristic form and the \"Turkish Form of the Beliefs About Third-hand Smoke Scale\".</p><p><strong>Results: </strong>The mean age was 58.52±14.01, with 73% of the participants being female, and 58% reported not smoking. They had a moderate Third-hand Smoke Scale (3.53±0.45). The impact of THS on health was 3.92±0.48 and Persistence in the Environment was 3.21±0.57. Education, smoking, and having cancer relatives were significantly associated with the THS scale scores.</p><p><strong>Conclusion: </strong>None of the participants had previously heard of the concept of THS. Beliefs about the harms of THS exposure were moderate. They believed that THS has a more harmful impact on health than its persistence in the environment. Graduate degrees, smoking, and those with cancer relatives believed the harms of third-hand exposure more than the others.</p>","PeriodicalId":75221,"journal":{"name":"Thoracic research and practice","volume":"26 2","pages":"55-60"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796301/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Depression Paradox in Cardiovascular Outcomes of Adult Patients with Obstructive Sleep Apnea: Insights from 2 Million Nationwide Hospitalizations.","authors":"Rupak Desai, Sashwath Srikanth, Shaylika Chauhan, Zainab Gandhi, Warda Shahnawaz, Aleen Rahman, Bisharah Rizvi, Akhil Jain","doi":"10.4274/ThoracResPract.2024.23132","DOIUrl":"10.4274/ThoracResPract.2024.23132","url":null,"abstract":"<p><strong>Objective: </strong>Depression is a frequent comorbidity in obstructive sleep apnea (OSA) patients. There is a scarcity of data on the impact of depression on the outcomes of OSA.</p><p><strong>Material and methods: </strong>Using the National Inpatient Sample (2018), we identified hospitalizations in the US with OSA. Following propensity-score matching, the two cohorts of OSA with depression (OSA+D+) vs. without depression (OSA+D-) were compared for demographic and comorbidities profiles differences. Multivariable regression analyses were performed to assess the odds of events with depression versus those without.</p><p><strong>Results: </strong>Of 2,169.730 hospitalizations in patients with OSA, 20.1% had comorbid depression. Matched cohorts included 846,150 admissions in both groups: OSA+D+ and OSA+D-. Both cohorts predominantly comprised Caucasians, the elderly (median age, 64 vs. 65 years), and females (55.5% vs. 55.2%). OSA+D+ cohort had a higher prevalence of hypertension, diabetes, hyperlipidemia, congestive heart failure, anemia, smoking, substance abuse, prior myocardial infarction (MI), transient ischemic attack (TIA), TIA/stroke, and venous thromboembolism than the OSA+D- group (all <i>P</i> < 0.001). Paradoxically, there was decreased risk of all-cause mortality [odds ratios (OR): 0.79, 95% confidence interval (CI): 0.73-0.86], major adverse cardiac and cerebrovascular events (OR: 0.83, 95% CI: 0.80-0.87), acute MI (OR: 0.80, 95% CI: 0.76-0.85), dysrhythmia/atrial fibrillation (OR: 0.81, 95% CI: 0.79-0.83), and cardiac arrest including ventricular fibrillation (OR: 0.65, 95% CI: 0.73-0.82) in the OSA+D+ cohort (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>OSA+D+ patients had better in-hospital outcomes as compared to OSA+D- despite having a higher burden of comorbidities. Additional research is warranted to validate this paradoxical effect of depression in OSA.</p>","PeriodicalId":75221,"journal":{"name":"Thoracic research and practice","volume":"26 2","pages":"43-47"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Relationship Between Gender and Women's Tobacco Use: An Ecological Analysis with Country-level Data.","authors":"Hanife Ece Erik, Tülin Çoban, Lütfiye Hilal Özcebe","doi":"10.4274/ThoracResPract.2024.24072","DOIUrl":"10.4274/ThoracResPract.2024.24072","url":null,"abstract":"<p><strong>Objective: </strong>Health and well-being are profoundly influenced by gender and its dimensions. This study explores the intricate relationship between gender roles and tobacco use.</p><p><strong>Material and methods: </strong>The study investigates correlations between the Gender Development Index (GDI), the Global Gender Gap Index (GGGI), and its sub-indicators-critical markers of gender equality-and tobacco prevalence and tobacco-related mortality. Statistical analyses, conducted using the Statistical Package for Social Science and Microsoft Excel, involve Spearman correlation analysis for continuous numerical data and the Kruskal-Wallis H test for differences between means.</p><p><strong>Results: </strong>As per the GDI, a decrease in gender inequality correlates with an increase in tobacco prevalence among women. The highest prevalence of tobacco use in women is found in countries within GDI group 1, with the lowest observed in group 5, characterized by pronounced gender inequality. A moderate positive correlation is identified between the prevalence of tobacco use in women and the GDI, GGGI, and the education sub-component of GGGI. Similarly, a moderate positive relationship is observed between tobacco-related mortality in women and the education subcomponent of GGGI. Education exhibits the highest correlation with both tobacco prevalence and tobacco-related mortality in women.</p><p><strong>Conclusion: </strong>The increased prevalence of tobacco use among women in countries with high education and socioeconomic status suggests the early stages of the tobacco epidemic. Smoking cessation remains a persistent challenge, especially for women. The study emphasizes the imperative for tailored gender-specific policies, highlighting the integration of gender considerations into health promotion and public health initiatives.</p>","PeriodicalId":75221,"journal":{"name":"Thoracic research and practice","volume":"26 2","pages":"61-68"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In Response to: Evaluation of Long-Coronavirus Disease-2019 Cases Readmitted to Intensive Care Units due to Acute Respiratory Failure: Point Prevalence Study","authors":"Eylem Tunçay","doi":"10.5152/ThoracResPract.2024.240752","DOIUrl":"10.5152/ThoracResPract.2024.240752","url":null,"abstract":"","PeriodicalId":75221,"journal":{"name":"Thoracic research and practice","volume":"1 1","pages":"87"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Global Burden of Tracheal, Bronchus, and Lung Cancer in Adults Over 55 Years Old Based on Socio demographic Status and Geographical and Gender Differences from 2010-2021.","authors":"Afrooz Mazidimoradi, Elham Shabani, Fatemeh Rezaei, Fariba Shahraki-Sanavi, Zahra Shahabinia, Leila Allahqoli, Hamid Salehiniya","doi":"10.4274/ThoracResPract.2024.24081","DOIUrl":"https://doi.org/10.4274/ThoracResPract.2024.24081","url":null,"abstract":"<p><strong>Objective: </strong>This study presented the tracheal, bronchus, and lung cancer (TBLC) trend in adults ≥55 based on the socio-demographic index and geographical regions.</p><p><strong>Material and methods: </strong>We obtained annual TBLC data from 2010 to 2021 from the 2021 Global Burden of Disease (GBD) Study and analyzed the incidence, death rates, and disability-adjusted life years (DALYs) rates across different geographical classifications of 204 national and territorial.</p><p><strong>Results: </strong>In adults ≥55 years, the TBLC incidence rate decreased from 2010 to 2021 by globally 20.9% and 9.6% in males, while increasing by 3.8% in females. Approximately 60% of TBLC cases occurred in Asian countries. European countries exhibit the highest incidence rate (169.16 per 100,000). Males across all continents showed a decreasing trend, only the Americas reported a decreasing trend for women, with a noted change of 17.3%. The Western Pacific Region (World Health Organization region), East Asia (GBD region), Monaco, and countries with advanced health systems reported the highest incidence, death, and DALY numbers and rates for all genders. World Bank Upper middle-income countries recorded the highest DALY numbers and rates, incidence, and death numbers, all showing a downward trend, similar to high-income countries.</p><p><strong>Conclusion: </strong>The global burden of TBLC is predominantly in Asian countries (mainly East Asia), with a slower decrease in incidence, death, DALY, and burden rates. Therefore, reducing exposure to risk factors, expanding screening and diagnostic programs, especially for high-risk male smokers and females, and improving treatment procedures to reduce the progression of this cancer are urgent.</p>","PeriodicalId":75221,"journal":{"name":"Thoracic research and practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Latent Tuberculosis Infection in Inflammatory Rheumatic Diseases Before Biological and Synthetic DMARD Treatment: Results from Three Rheumatology Centers in Different Regions of Türkiye.","authors":"Abdulvahap Kahveci, Cansu Akleylek, Sevilay Batıbay","doi":"10.4274/ThoracResPract.2024.24098","DOIUrl":"https://doi.org/10.4274/ThoracResPract.2024.24098","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to investigate the prevalence of latent tuberculosis (TB) infection (LTBI) and its associated factors in patients with inflammatory rheumatic diseases (IRDs) prior to the administration of biologic and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs/tsDMARDs).</p><p><strong>Material and methods: </strong>A total of 402 patients with IRDs who were receiving bDMARDs/tsDMARDs from tertiary rheumatology centers in three different geographical regions were included in the study. Demographic, clinical, and TB-related characteristics were documented. The patients were divided into two groups, namely those with LTBI and non-LTBI, and their data were subjected to comparative analysis. The impact of various factors on LTBI was evaluated by regression analysis.</p><p><strong>Results: </strong>The prevalence of LTBI was 50.7% (204/402) before bDMARD/tsDMARD therapy. The proportion of male patients [108 (52.9%) vs. 84 (42.3%); <i>P</i> = 0.03] and the prevalence of smoking [102 (50.0%) vs. 64 (32.3%); <i>P</i> = 0.001] were statistically higher in the LTBI group. The preference for adalimumab was statistically lower in patients with LTBI (30.4%, 62/204 vs. 45.9%, 91/198; <i>P</i> = 0.021). Smoking [odds ratio (OR) 95% confidence interval (CI): 1.46 (1.16-1.65); <i>P</i> = 0.007], and duration of bDMARD use [OR 95% CI: 1.10 (1.03-1.17); <i>P</i> = 0.013] were significantly associated with LTBI. Isoniazid was used as the prophylactic agent in 96.45% (190/204) of patients, whereas there were no cases of TB reactivation among the three cohorts.</p><p><strong>Conclusion: </strong>The present study demonstrated that more than half of patients with IRDs undergoing advanced therapies have LTBI, with this infection being associated with male sex, smoking status, and duration of bDMARD use. Furthermore, this study indicates that appropriate screening and treatment of LTBI in patients with rheumatic diseases are associated with favorable clinical outcomes.</p>","PeriodicalId":75221,"journal":{"name":"Thoracic research and practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}